Xvivo Perfusion Ab (publ)

(OTC) XVIPF

Current Price$29.00

Market Cap$913.52M

Since IPO (2014)+390%

5 Year-31%

1 Year-12%

1 Month+27%

Xvivo Perfusion Ab (publ) Financials at a Glance

Market Cap

$913.52M

Revenue (TTM)

SEK 832.66M

Net Income (TTM)

SEK 73.75M

EPS (TTM)

$0.25

P/E Ratio

114.86

Dividend

$0.00

Beta (Volatility)

0.27 (Low)

Dividend

$0.00

Beta (Volatility)

0.27 (Low)

Price

$29.00

Volume

100

Open

$29.00

Price

$29.00

Volume

100

Open

$29.00

Previous Close

$29.00

Daily Range

$29.00 - $29.00

52-Week Range

$16.98 - $32.90

Estimated Earnings Date

Jul 14, 2026

Dividend

$0.00

Beta (Volatility)

0.27 (Low)

Price

$29.00

Volume

100

Open

$29.00

Previous Close

$29.00

Daily Range

$29.00 - $29.00

52-Week Range

$16.98 - $32.90

Estimated Earnings Date

Jul 14, 2026

XVIPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xvivo Perfusion Ab (publ)

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

199

CEO

Christoffer Rosenblad, MBA

Website

www.xvivogroup.com

Headquarters

Gothenburg, 412 51, SE

XVIPF Financials

Key Financial Metrics (TTM)

Gross Margin

65%

Operating Margin

12%

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

0.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$913.52M

Shares Outstanding

31.50M

Volume

100

Avg. Volume

9.484

Financials (TTM)

Gross Profit

SEK 532.16M

Operating Income

SEK 92.78M

EBITDA

SEK 152.75M

Operating Cash Flow

SEK 100.81M

Capital Expenditure

-SEK 100.81M

Free Cash Flow

SEK 0.00

Cash & ST Invst.

SEK 291.36M

Total Debt

SEK 237.29M

Xvivo Perfusion Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

SEK 240.96M

+10.2%

Gross Profit

SEK 171.04M

+6.6%

Gross Margin

70.98%

N/A

Market Cap

$913.52M

N/A

Market Cap/Employee

$4.73M

N/A

Employees

193

N/A

Net Income

SEK 36.30M

+392.8%

EBITDA

SEK 31.94M

+20.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

SEK 308.14M

-2.4%

Total Debt

SEK 0.00

N/A

Accounts Receivable

SEK 189.33M

+2.5%

Inventory

SEK 227.22M

+0.6%

Long Term Debt

SEK 0.00

N/A

Short Term Debt

SEK 11.32M

+25.5%

Return on Assets

2.99%

N/A

Return on Invested Capital

4.26%

N/A

Free Cash Flow

SEK 65.34M

+528.5%

Operating Cash Flow

SEK 65.34M

+528.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVNBFAvon Technologies Plc

AVNBFAvon Technologies Plc$22.49+0.00%

SOLTFNxera Pharma Co., Ltd.

SOLTFNxera Pharma Co., Ltd.$6.19+0.00%

CALZFPolyNovo Limited

CALZFPolyNovo Limited$0.68+0.00%

VBIZFViva Biotech Holdings

VBIZFViva Biotech Holdings$0.16+8.73%

CLVSFCellaVision AB (publ)

CLVSFCellaVision AB (publ)$13.49+0.00%

LBLTFLattice Biologics Ltd.

LBLTFLattice Biologics Ltd.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About XVIPF

What is the current price of Xvivo Perfusion Ab (publ)?

Xvivo Perfusion Ab (publ) is trading at $29.00 per share.

What is the 52-week range for Xvivo Perfusion Ab (publ)?

Over the past 52 weeks, Xvivo Perfusion Ab (publ) has traded between $16.98 and $32.90.

How much debt does Xvivo Perfusion Ab (publ) have?

As of the most recent reporting period, Xvivo Perfusion Ab (publ) reported total debt of SEK 12.88M.

How much cash does Xvivo Perfusion Ab (publ) have on hand?

Xvivo Perfusion Ab (publ) reported SEK 32.35M in cash and cash equivalents in its most recent financial results.

What is Xvivo Perfusion Ab (publ)’s dividend yield?

Xvivo Perfusion Ab (publ) does not currently have a dividend yield.

Xvivo Perfusion Ab (publ)

Xvivo Perfusion Ab (publ) Financials at a Glance

XVIPF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Xvivo Perfusion Ab (publ)

XVIPF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Xvivo Perfusion Ab (publ) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About XVIPF

What is the current price of Xvivo Perfusion Ab (publ)?

What is the 52-week range for Xvivo Perfusion Ab (publ)?

How much debt does Xvivo Perfusion Ab (publ) have?

How much cash does Xvivo Perfusion Ab (publ) have on hand?

What is Xvivo Perfusion Ab (publ)’s dividend yield?

Premium Investing Services